Title: McCullough Professor of Cancer Research, Clinical Research Director
Company: University of Texas MD Anderson Cancer Center
Location: Houston, Texas, United States
Charles Cleeland, the McCullough Professor of Cancer Research and Clinical Research Director at the University of Texas’ MD Anderson Cancer Center, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in the field of cancer and symptoms research.
A lifelong devotee to the study of cancer, symptom research and pain management, Dr. Cleeland prepared for his career at Washington University in St. Louis, Missouri, where he earned a PhD in 1967. He started as a professor of neurology at the University of Wisconsin—Madison, and worked there for more than 25 years, until 1996. Dr. Cleeland became a diplomate of the American Board of Professional Psychology in 1976, and a member of the American Pain Society in 1995.
Upon his departure from the University of Wisconsin—Madison, Dr. Cleeland accepted a new position at the University of Texas’ MD Anderson Cancer Center, where he has served as a professor of the Department of Symptom Research since 1996. Currently, he provides his expertise and skills as the clinical research director of the Department of Symptom Research, and as the center’s McCullough professor of cancer research. In the coming years, he plans to retire, continuing his service to the medical profession by working as a consultant and serving on expert committees.
In the late 1980s, Dr. Cleeland was inspired by his work with the World Health Organization (WHO). He became a consultant for the implementation of the WHO’s guidelines for pain management for cancer, primarily focusing on the United States. Working with the Pain Research Group of the WHO’s Collaborating Centre for Symptom Evaluation in Cancer Care, Dr. Cleeland helped develop ways to screen patients for pain with simple instruments such as the Brief Pain Inventory.
Throughout his career, Dr. Cleeland’s goal has been to publicize and examine the poor level of treatment for the symptoms of cancer. He was recognized for his work on pain management with the Fordyce Award from the American Pain Society, has contributed to myriad published works and papers in professional journals, and became a fellow of the American Psychological Association in 1982. He cites Dr. Frank Forester, head of neurology at the University of Wisconsin, and Dr. John Bonita at the University of Washington, as mentors and influences in his career.
Contact Dr. Cleeland: